This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Explore key tips for retirement planning to secure your financial future. Understand what steps to take for a comfortable retirement.
26,014 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
As the AI infrastructure boom intensifies, communities push back against giant data centers. Kevin O’Leary’s Stratos ...
This summer's extreme weather could upend real estate plans and loan decisions. Learn which states face heightened cl...
The Federal Reserve's May inflation forecast signals higher costs and tougher markets ahead. This guide breaks down w...
The CLARITY Act cleared the Senate Banking Committee, advancing a path toward floor consideration and a broader regul...
Nebius Group flags a fragile link between borrowing costs and AI investment. The remarks underscore how rate moves fr...
As the AI arms race accelerates, Microsoft leans on Copilot to reverse signals of lost momentum. Early traction and p...
A high-profile finale featuring Paul McCartney highlighted the financial calculus networks face as linear TV ad spend...
Starting with $500 in crypto doesn't have to be chaotic. This guide shows a clear, actionable plan to pick the best c...
MicroStrategy is pursuing a sizable buyback of zero-coupon convertible notes, a move some critics say reveals liquidi...
Analysts often set price targets to frame potential moves for AI stocks. This article breaks down how those targets a...
Lenders push automation and AI in a bid to speed closings, but costs rise and internal handoffs persist. Analysts wei...